scholarly journals Correction to: Opioid Use Disorder Stigma Reduction Through Story Telling Narrative and Sharing: a Qualitative Review and Lessons Learned

Author(s):  
Hailey Judd ◽  
Cristian L. Meier ◽  
Ashley C. Yaugher ◽  
Emma Campbell ◽  
Kandice Atismé-Bevins
2021 ◽  
Vol 136 (1_suppl) ◽  
pp. 9S-17S
Author(s):  
Jessica C. Acharya ◽  
B. Casey Lyons ◽  
Vijay Murthy ◽  
Jennifer Stanley ◽  
Carly Babcock ◽  
...  

Federal and state enforcement authorities have increasingly intervened on the criminal overprescribing of opioids. However, little is known about the health effects these enforcement actions have on patients experiencing disrupted access to prescription opioids or medication-assisted treatment/medication for opioid use disorder. Simultaneously, opioid death rates have increased. In response, the Maryland Department of Health (MDH) has worked to coordinate mitigation strategies with enforcement partners (defined as any federal, state, or local enforcement authority or other governmental investigative authority). One strategy is a standardized protocol to implement emergency response functions, including rapidly identifying health hazards with real-time data access, deploying resources locally, and providing credible messages to partners and the public. From January 2018 through October 2019, MDH used the protocol in response to 12 enforcement actions targeting 34 medical professionals. A total of 9624 patients received Schedule II-V controlled substance prescriptions from affected prescribers under investigation in the 6 months before the respective enforcement action; 9270 (96%) patients were residents of Maryland. Preliminary data indicate fatal overdose events and potential loss of follow-up care among the patient population experiencing disrupted health care as a result of an enforcement action. The success of the strategy hinged on endorsement by leadership; the establishment of federal, state, and local roles and responsibilities; and data sharing. MDH’s approach, data sources, and lessons learned may support health departments across the country that are interested in conducting similar activities on the front lines of the opioid crisis.


2021 ◽  
Vol 82 (2) ◽  
pp. 214-218
Author(s):  
Tami L. Mark ◽  
William J. Parish ◽  
Ellen M. Weber ◽  
Gary A. Zarkin

Author(s):  
Rebecca H Burns ◽  
Cassandra M Pierre ◽  
Jai G Marathe ◽  
Glorimar Ruiz-Mercado ◽  
Jessica L Taylor ◽  
...  

Abstract Massachusetts is one of the epicenters of the opioid epidemic and has been severely impacted by injection-related viral and bacterial infections. A recent increase in newly diagnosed human immunodeficiency virus (HIV) infections among persons who inject drugs in the state highlights the urgent need to address and bridge the overlapping epidemics of opioid use disorder (OUD) and injection-related infections. Building on an established relationship between the Massachusetts Department of Public Health (MDPH) and Boston Medical Center (BMC), the Infectious Diseases section has contributed to the development and implementation of a cohesive response involving ambulatory, inpatient, emergency department and community-based services. We describe this comprehensive approach including the rapid delivery of antimicrobials for the prevention and treatment of HIV, sexually transmitted diseases, systemic infections such as endocarditis, bone and joint infections, as well as curative therapy for chronic hepatitis C virus (HCV) in a manner that is accessible to patients on the addiction-recovery continuum. We also provide an overview of programs that provide access to medications for opioid use disorder (MOUD), harm reduction services including overdose education and distribution of naloxone. Finally, we outline lessons learned to inform initiatives in other settings.


2020 ◽  
Vol 43 (2) ◽  
pp. 22
Author(s):  
Stacey Whitman ◽  
Cristina Zaganelli ◽  
Sharleen Luzny

Emergency Strategic Clinical NetworkTM Quality and Innovation Forum Presentation Proposal Name: xx Position (e.g. patient care manager, professor): Manager Primary Affiliation: (AHS) Other: AHS Project Title: iOAT in the ED – Lessons Learned Hospital: All adult sites in Calgary Location: Calgary Team Members: xx & xx Background Deaths related to opioid poisoning have continued to climb over the last few years. The Injectable Opioid Agonist Treatment program (iOAT) provides injectable hydromorphone to those individuals with moderate to severe opioid use disorder and a history of injection drug use who have been unsuccessful with oral OAT and continue to be at high risk for opioid poisoning. Working with the emergency departments (ED) was identified as a critical step in the initial roll out of iOAT. Implementation  The iOAT program began operating in October 2018. The clinic provides prescribed hydromorphone to clients within the program. Additionally, the team is comprised of physicians, nurse practitioners, nurses, social worker, peer support workers and administrative support to provide comprehensive wrap around care to every client that is registered to the program. It was recognized early on that the clients that were being served by iOAT were also high users of the ED and UCCs. Being part of iOAT became a factor that needed to be considered when these clients presented to the ED due to their prescription of hydromorphone. Working with management, medical leadership, and nurse educators, support and education were provided to ensure that iOAT clients were provided with optimal care when in the ED. Ongoing communication has been the primary strategy that has been used. Evaluation Methods  The evaluation for this project has been informal and ongoing. The medical team at iOAT has worked with the medical team for the Calgary EDs to develop a detailed treatment plan that is visible on SCM. Telephone and emails have been the primary mode of feedback for both parties, and the plan is adjusted as necessary along the way. Results Improving the knowledge and understanding for all staff involved to understand iOAT and the role of the ED has been demonstrated to be effective when clients stay in the ED and don’t leave against medical advice, which likely occurred before. Additionally, the trust that is built within the iOAT clinic is maintained when the ED is a partner in care and as appropriate, provides them with the dosing that they would normally receive at iOAT. Advice and Lessons Learned 1)      Involve the emergency department management in planning or initial implementation 2)      Communicate, Communicate, Communicate 3)      Use continuous feedback to adjust to find the best strategies to provide patient care


2018 ◽  
Vol 39 (2) ◽  
pp. 139-144 ◽  
Author(s):  
Jessica J. Wyse ◽  
Adam J. Gordon ◽  
Steven K. Dobscha ◽  
Benjamin J. Morasco ◽  
Elizabeth Tiffany ◽  
...  

2021 ◽  
pp. 1-7
Author(s):  
Evan S. Cole ◽  
Ellen DiDomenico ◽  
Sherri Green ◽  
Susan K. R. Heil ◽  
Tandrea Hilliard ◽  
...  

2020 ◽  
Vol 21 (3) ◽  
pp. 340-343
Author(s):  
Mary T. Paterno ◽  
Denise Leckenby ◽  
Mark C. Pachucki

With the national increase in opioid use disorder among pregnant and parenting women, innovative mechanisms are being utilized to engage with mothers to build social support and promote recovery. This is particularly important in rural settings where other support systems may be limited. Digital storytelling is an interactive tool that often facilitates social connectedness among participants and may foster empowerment and community building among mothers in recovery. We conducted one digital storytelling workshop with rural mothers in recovery in 2018 to examine the feasibility of employing this method to engage with mothers in recovery in a community setting and promote social support among participants. In this article, we describe what we learned from working with the mothers to guide others considering using digital storytelling with women with opioid use disorder in future research or public health intervention projects.


Sign in / Sign up

Export Citation Format

Share Document